Cogent Biosciences, Inc. (COGT)
33.29
-0.12
(-0.36%)
USD |
NASDAQ |
Sep 14, 12:52
Cogent Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | -16.02K% |
| June 30, 2020 | -1.40K% |
| March 31, 2020 | -86.67% |
| December 31, 2019 | 15.02% |
| September 30, 2019 | -1.17K% |
| June 30, 2019 | -335.1% |
| March 31, 2019 | -382.9% |
| Date | Value |
|---|---|
| December 31, 2018 | -226.2% |
| September 30, 2018 | -497.7% |
| June 30, 2018 | -541.6% |
| March 31, 2018 | -304.1% |
| December 31, 2017 | -315.9% |
| September 30, 2017 | -301.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -539.3% |
| Apogee Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -84.42% |
| Return on Assets | -55.86% |
| Return on Invested Capital | -61.29% |
| Return on Net Operating Assets | -1.54K% |